-
00:00
1.
index 1
-
01:24
2.
HBx-downregulated circSFMBT2 in HCC cell lines
-
12:05
3.
HBx-downregulated circSFMBT2 in HCC cell lines
-
16:00
4.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
16:52
5.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
23:51
6.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
28:40
7.
CircSFMBT2 inhibits HCC metastasis in vitro
-
28:46
8.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
34:15
9.
CircSFMBT2 inhibits HCC metastasis in vitro
-
35:44
10.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
35:45
11.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
35:46
12.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
35:47
13.
HBx-downregulated circSFMBT2 in HCC cell lines
-
35:50
14.
HBx-downregulated circSFMBT2 in HCC cell lines
-
36:32
15.
HBx-downregulated circSFMBT2 in HCC cell lines
-
36:32
16.
Level of CircSFMBT2 in HBV(+) or HBV(-) tumorous tissues and paired adjacent nontumorous tissues
-
36:33
17.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
36:39
18.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
36:39
19.
CircSFMBT2 inhibits HCC metastasis in vitro
-
42:59
20.
CircSFMBT2 inhibits HCC metastasis in vitro
-
45:58
21.
CircSFMBT2 inhibits HCC metastasis in vitro
-
46:02
22.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
46:02
23.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
47:03
24.
CircSFMBT2 is expressed at low levels in HCC and correlates with poor prognosis and invasion
-
47:03
25.
CircSFMBT2 inhibits HCC metastasis in vitro
-
47:05
26.
CircSFMBT2 inhibits HCC metastasis in vitro
-
47:07
27.
CircSFMBT2 inhibits HCC metastasis in vivo
-
50:41
28.
CircSFMBT2 acts as a sponge of miR-665
-
1:02:07
29.
CircSFMBT2 acts as a sponge of miR-665
-
1:02:11
30.
CircSFMBT2 acts as a sponge of miR-665
-
1:04:23
31.
CircSFMBT2 acts as a sponge of miR-665
-
1:07:59
32.
CircSFMBT2 acts as a sponge of miR-665
-
1:08:05
33.
CircSFMBT2 acts as a sponge of miR-665
-
1:08:54
34.
CircSFMBT2 acts as a sponge of miR-665
-
1:09:46
35.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
1:11:41
36.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
1:16:17
37.
CircSFMBT2 regulates HCC metastasis through the miR-665/TIMP3 axis
-
1:17:20
38.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
1:17:26
39.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
1:17:36
40.
HBx facilitates HCC metastasis through circSFMBT2/miR-665/TIMP3 pathways
-
1:17:40
41.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
1:20:56
42.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
1:21:04
43.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
1:21:57
44.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
1:22:38
45.
HBx downregulates circSFMBT2 via interacting with DHX9 and promoting DHX9 to bind flanking Alu elements
-
1:23:50
46.
Slide 24